NCT05278975 2024-01-26
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
RS Oncology LLC
Phase 1/2 Unknown
RS Oncology LLC
Multitude Therapeutics Inc.
Momotaro-Gene Inc.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.